| Literature DB >> 34693001 |
David Virós Porcuna1, Laura Pardo Muñoz1, Constanza Viña Soria1, Viviana Nicastro1, Mar Palau Viarnès1, Carlos Pollán Guisasola1.
Abstract
OBJECTIVE: Surgery is the standard treatment for most tumors in the prestyloid parapharyngeal space (PPS) but it can be a challenging procedure because of the anatomical complexity of the area. Prestyloid surgery can be performed with various lateral approaches or with a medial approach using transoral robotic surgery (TORS)-either alone or in combination with a transcervical incision. We have retrospectively compared our center's results with lateral and medial approaches.Entities:
Keywords: oropharynx; parapharygeal space tumors; parotid; salivary glands; ultrasound/imaging
Year: 2021 PMID: 34693001 PMCID: PMC8513456 DOI: 10.1002/lio2.662
Source DB: PubMed Journal: Laryngoscope Investig Otolaryngol ISSN: 2378-8038
FIGURE 1Decision‐making tree for surgical approaches in prestyloid PPS tumors. ICA, internal carotid artery; TO, transoral
FIGURE 2MRI axial and coronal slices showing prestyloid PPS tumors. (A,B) Independent parotid gland tumors treated with TORS. (C,D) Prestyloid tumor with lateral extension due to primary parotid involvement treated with TORS in combination with a transcervical approach
Patient and tumor characteristics and surgical outcomes in 28 patients with prestyloid tumors
| All patients | Lateral approach | Medial approach | |
|---|---|---|---|
| N = 28 | N = 14 | N = 14 | |
| N (%) | N (%) | N (%) | |
|
| |||
| Median (range) | 60.18 (34‐85) | 62.36 (42‐85) | 58 (34‐76) |
|
| |||
| Male | 15 (53.57) | 8 (57.1) | 7 (50) |
| Female | 13 (46.43) | 6 (42.9) | 7 (50) |
|
| — | ||
| Transcervical | 1 (3.57) | 1 (7.14) | — |
| Transcervical‐transparotid | 11 (39.28) | 11 (78.57) | — |
| Transcervical‐transmandibular | 2 (7.14) | 2 (14.29) | — |
| TORS alone | 12 (42.85) | — | 12 (85.71) |
| TORS + transcervical | 2 (7.14) | — | 2 (14.29) |
|
| |||
| Pleomorphic adenoma | 8 (28.57) | 6 (42.85) | 2 (14.28) |
| Warthin's tumor | 1 (3.57) | 1 (7.14) | — |
| Carcinoma ex pleomorphic adenoma | 2 (7.14) | 1 (7.14) | 1 (7.14) |
| Adenoid cystic carcinoma | 1 (3.57) | 1 (7.14) | — |
| Salivary duct carcinoma | 1 (3.57) | 1 (7.14) | — |
| Schwannoma | 1 (3.57) | — | 1 (7.14) |
| Hemangioma | 2 (7.14) | — | 2 (14.28) |
| Lipoma | 1 (3.57) | — | 1 (7.14) |
| Histiocytoma | 1 (3.57) | — | 1 (7.14) |
| Metastasis of squamous cell carcinoma | 7 (25.0) | 2 (14.28) | 5 (35.7) |
| Myoepithelioma | 1 (3.57) | 1 (7.14) | — |
| Lymphoepithelial lesion | 1 (3.57) | — | 1 (7.14) |
| Liposarcoma | 1 (3.57) | 1 (7.14) | — |
|
| |||
| Benign | 17 (60.71) | 9 (64.29) | 8 (57.14) |
| Malignant | 11 (39.29) | 5 (35.71) | 6 (42.86) |
| Mean tumor size, cm3 | 19.4 | 21.66 | 17.15 |
| Mean max tumor length, cm | 3.75 | 3.6 | 3.9 |
| Need for feeding tube | 8 (28.6) | 4 (28.6) | 4 (28.6) |
| Mean duration of surgery, min (range) | 182.9 (40‐340) | 221.4 (100‐340) | 133.3 (40‐240) |
| Mean length of hospital stay, days | 7.32 | 8.9 | 5.8 |
| Rate of postsurgical complications | 39.3% | 64.3% | 14.3% |
| Free margin rate | 78.6% | 78.6% | 78.6% |
| 2‐year relapse free survival rate | 74.1% | 69.3% | 78.6% |
Postsurgical complications for all patients and according to the surgical approach used
| Complication | All patients | Lateral approach | Medial approach |
|---|---|---|---|
| N = 28 | N = 14 | N = 14 | |
| N (%) | N (%) | N (%) | |
| None | 17 (60.7) | 5 (35.7) | 12 (85.7) |
| Wound dehiscence | 1 (3.6) | 1 (7.1) | 0 |
| Transient facial palsy | 3 (10.7) | 3 (21.4) | 0 |
| Permanent facial palsy | 5 (17.8) | 5 (35.7) | 0 |
| Cervical hematoma | 1 (3.6) | 0 | 1 (7.1) |
| Pharyngeal wound dehiscence | 1 (3.6) | 0 | 1 (7.1) |
Of the three patients treated with a lateral approach who had transient facial palsy, two had benign tumors and one had a malignant tumor.
Of the five patients treated with a lateral approach who had permanent facial palsy, four had benign tumors and one had a malignant tumor.